MY144318A - Methods of treating hiv infection. - Google Patents

Methods of treating hiv infection.

Info

Publication number
MY144318A
MY144318A MYPI20051136A MYPI20051136A MY144318A MY 144318 A MY144318 A MY 144318A MY PI20051136 A MYPI20051136 A MY PI20051136A MY PI20051136 A MYPI20051136 A MY PI20051136A MY 144318 A MY144318 A MY 144318A
Authority
MY
Malaysia
Prior art keywords
methods
hiv infection
treating hiv
treating
aids
Prior art date
Application number
MYPI20051136A
Other languages
English (en)
Inventor
Pin-Fang Lin
Beata Nowicka-Sans
Gregory Yamanaka
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34961940&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY144318(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of MY144318A publication Critical patent/MY144318A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MYPI20051136A 2004-03-24 2005-03-17 Methods of treating hiv infection. MY144318A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55576704P 2004-03-24 2004-03-24

Publications (1)

Publication Number Publication Date
MY144318A true MY144318A (en) 2011-08-29

Family

ID=34961940

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20051136A MY144318A (en) 2004-03-24 2005-03-17 Methods of treating hiv infection.

Country Status (30)

Country Link
US (1) US7776863B2 (en:Method)
EP (1) EP1732604B1 (en:Method)
JP (1) JP4847441B2 (en:Method)
KR (1) KR101158140B1 (en:Method)
CN (1) CN1956720B (en:Method)
AR (1) AR048333A1 (en:Method)
AT (1) ATE474602T1 (en:Method)
AU (1) AU2005235116B2 (en:Method)
BR (1) BRPI0509140A (en:Method)
CA (1) CA2561146C (en:Method)
CY (1) CY1111613T1 (en:Method)
DE (1) DE602005022420D1 (en:Method)
DK (1) DK1732604T3 (en:Method)
ES (1) ES2347801T3 (en:Method)
GE (1) GEP20104925B (en:Method)
HR (1) HRP20100434T1 (en:Method)
IL (1) IL178141A (en:Method)
IN (1) IN2012DN06436A (en:Method)
MY (1) MY144318A (en:Method)
NO (1) NO337116B1 (en:Method)
NZ (1) NZ549778A (en:Method)
PE (1) PE20060148A1 (en:Method)
PL (1) PL1732604T3 (en:Method)
PT (1) PT1732604E (en:Method)
RU (1) RU2367439C2 (en:Method)
SI (1) SI1732604T1 (en:Method)
TW (1) TWI347184B (en:Method)
UA (1) UA88463C2 (en:Method)
WO (1) WO2005102392A2 (en:Method)
ZA (1) ZA200607959B (en:Method)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040110785A1 (en) * 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US7745625B2 (en) 2004-03-15 2010-06-29 Bristol-Myers Squibb Company Prodrugs of piperazine and substituted piperidine antiviral agents
US20060100432A1 (en) * 2004-11-09 2006-05-11 Matiskella John D Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US20060100209A1 (en) * 2004-11-09 2006-05-11 Chong-Hui Gu Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
DK1942108T3 (da) 2005-10-28 2013-12-09 Ono Pharmaceutical Co Forbindelse indeholdende basisk gruppe samt anvendelse deraf
ES2407115T3 (es) 2005-11-18 2013-06-11 Ono Pharmaceutical Co., Ltd. Compuesto que contiene un grupo básico y uso del mismo
US7851476B2 (en) * 2005-12-14 2010-12-14 Bristol-Myers Squibb Company Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US7807671B2 (en) * 2006-04-25 2010-10-05 Bristol-Myers Squibb Company Diketo-piperazine and piperidine derivatives as antiviral agents
US7501419B2 (en) * 2006-04-25 2009-03-10 Bristol-Myers Squibb Company 4-Squarylpiperazine derivatives as antiviral agents
US7572810B2 (en) * 2006-06-08 2009-08-11 Bristol-Myers Squibb Company Alkene piperidine derivatives as antiviral agents
US7504399B2 (en) 2006-06-08 2009-03-17 Bristol-Meyers Squibb Company Piperazine enamines as antiviral agents
ES2389478T3 (es) * 2008-06-25 2012-10-26 Bristol-Myers Squibb Company Derivados de dicetopiperidina como inhibidores de la fijación del VIH
JP5433690B2 (ja) * 2008-06-25 2014-03-05 ブリストル−マイヤーズ スクイブ カンパニー 抗−ｈｉｖ薬としてのジケト縮合アゾロピペリジンおよびアゾロピペラジン
US20110295365A1 (en) * 2010-05-28 2011-12-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Anti-viral compositions and methods for administration
WO2012019003A1 (en) 2010-08-06 2012-02-09 Bristol-Myers Squibb Company Substituted indole and azaindole oxoacetyl piperazinamide derivatives
EP2646439B1 (en) 2010-12-02 2016-05-25 Bristol-Myers Squibb Company Alkyl amides as hiv attachment inhibitors
WO2012106189A1 (en) 2011-01-31 2012-08-09 Bristol-Myers Squibb Company Methods of making hiv attachment inhibitor prodrug compound and intermediates
WO2012142080A1 (en) 2011-04-12 2012-10-18 Bristol-Myers Squibb Company Thioamide, amidoxime and amidrazone derivatives as hiv attachment inhibitors
ES2616268T3 (es) 2011-08-29 2017-06-12 VIIV Healthcare UK (No.5) Limited Derivados condensados de diamina bicíclica como inhibidores de la unión de VIH
ES2609579T3 (es) 2011-08-29 2017-04-21 VIIV Healthcare UK (No.5) Limited Derivados espiro de diamina bicíclica como inhibidores de la unión del VIH
WO2013138436A1 (en) 2012-03-14 2013-09-19 Bristol-Myers Squibb Company Cyclolic hydrazine derivatives as hiv attachment inhibitors
EP2895472B1 (en) 2012-08-09 2016-11-23 VIIV Healthcare UK (No.5) Limited Tricyclic alkene derivatives as HIV attachment inhibitors
ES2616492T3 (es) 2012-08-09 2017-06-13 VIIV Healthcare UK (No.5) Limited Derivados de piperidina amida como inhibidores de la fijación del VIH
PT2978763T (pt) * 2013-03-27 2018-04-16 Viiv Healthcare Uk No 5 Ltd Derivados de 2-cetoamida como inibidores da ligação do vih
US11584797B2 (en) 2015-06-23 2023-02-21 Cytodyn Inc. Inhibition of CCL5 ligand binding to CCR5 receptor and alteration of CCR5/CCL5 axis signaling in inflammation, cancer, autoimmune, and other conditions
US20250237642A1 (en) * 2022-03-08 2025-07-24 Emory University Predictive model for variants associated with drug resistance and theranostic applications thereof
US12425371B2 (en) * 2022-09-16 2025-09-23 Cisco Technology, Inc. System and method for providing SCHC-based edge firewalling

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999045025A1 (en) * 1998-03-02 1999-09-10 The University Of North Carolina At Chapel Hill Acylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof
US6476034B2 (en) 2000-02-22 2002-11-05 Bristol-Myers Squibb Company Antiviral azaindole derivatives
US20040110785A1 (en) * 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US20030207910A1 (en) 2001-02-02 2003-11-06 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
RU2192870C1 (ru) * 2001-07-02 2002-11-20 Закрытое акционерное общество "Агрофарм ПитерСиб" Антивирусная композиция, способ получения ее активной компоненты и способ лечения вич-инфицированных больных этой композицией
PL370664A1 (en) * 2001-12-12 2005-05-30 Bristol-Myers Squibb Company Hiv integrase inhibitors
AU2002357379A1 (en) * 2001-12-21 2003-07-15 Anormed Inc. Chemokine receptor binding heterocyclic compounds with enhanced efficacy

Also Published As

Publication number Publication date
RU2006137555A (ru) 2008-04-27
JP2007530540A (ja) 2007-11-01
IL178141A (en) 2010-11-30
NO337116B1 (no) 2016-01-25
IL178141A0 (en) 2006-12-31
US20050215545A1 (en) 2005-09-29
RU2367439C2 (ru) 2009-09-20
TW200538117A (en) 2005-12-01
CY1111613T1 (el) 2015-10-07
ZA200607959B (en) 2008-06-25
WO2005102392A3 (en) 2006-07-20
ATE474602T1 (de) 2010-08-15
US7776863B2 (en) 2010-08-17
JP4847441B2 (ja) 2011-12-28
DK1732604T3 (da) 2010-11-15
KR101158140B1 (ko) 2012-06-19
BRPI0509140A (pt) 2007-09-04
TWI347184B (en) 2011-08-21
DE602005022420D1 (de) 2010-09-02
ES2347801T3 (es) 2010-11-04
HK1096540A1 (en) 2007-06-01
CA2561146A1 (en) 2005-11-03
SI1732604T1 (sl) 2010-10-29
PE20060148A1 (es) 2006-03-04
AR048333A1 (es) 2006-04-19
NZ549778A (en) 2010-09-30
IN2012DN06436A (en:Method) 2015-10-09
PL1732604T3 (pl) 2010-12-31
EP1732604B1 (en) 2010-07-21
GEP20104925B (en) 2010-03-25
WO2005102392A2 (en) 2005-11-03
NO20064547L (no) 2006-10-06
PT1732604E (pt) 2010-09-24
UA88463C2 (ru) 2009-10-26
AU2005235116A1 (en) 2005-11-03
HRP20100434T1 (hr) 2010-09-30
KR20070011322A (ko) 2007-01-24
CA2561146C (en) 2013-12-24
EP1732604A2 (en) 2006-12-20
CN1956720A (zh) 2007-05-02
CN1956720B (zh) 2010-12-15
AU2005235116B2 (en) 2011-03-31

Similar Documents

Publication Publication Date Title
MY144318A (en) Methods of treating hiv infection.
LUC00011I2 (en:Method)
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
TW200612910A (en) Medicaments comprising carbonyl compounds, and the use thereof
TW200509949A (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
WO2006034001A3 (en) Methods of treating hiv infection
IL181909A0 (en) Phosphoindoles as hiv inhibitors
SG162614A1 (en) Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors
TW200738700A (en) HIV integrase inhibitors
PL1891961T3 (pl) Zastosowanie 5'-metylotioadenozyny (mta) w zapobieganiu i/lub leczeniu chorób autoimmunologicznych i/lub odrzucania przeszczepu
WO2004009029A3 (en) Compositions and methods for treating and preventing infection
EP1303300A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANDIDIASIS
GB0300078D0 (en) Composition for the treatment of HIV and AIDS
DE60229624D1 (de) Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion
MX2007004040A (es) Uso para alfa-simpatomimeticos con estructura de 2-imidazolina.
MY140242A (en) BICYCLIC 6-ALKYLIDENE-PENEMS AS ß-LACTAMASES INHIBITORS
UA88325C2 (en) Phosphoindoles as hiv inhibitors
UA89625C2 (ru) Фосфонаты, монофосфонамидаты, бисфосфонамидаты для лечения вирусных заболеваний